Analysts See $0.86 EPS for Cboe Global Markets, Inc. (CBOE)

Darrin Black

Investors sentiment decreased to 1.47 in 2017 Q3. Its down 0.27, from 1.74 in 2017Q2. It dived, as 38 investors ...

Analysts See $0.40 EPS for Boardwalk Pipeline Partners, LP (BWP)

Maria Brooks

Investors sentiment decreased to 0.94 in 2017 Q3. Its down 0.05, from 0.99 in 2017Q2. It fall, as 20 investors ...

Arrowhead Pharmaceuticals, Inc. (ARWR) EPS Estimated At $-0.15

Henry Gaston

Analysts expect Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) to report $-0.15 EPS on February, 5.They anticipate $0.02 EPS change or 11.76 % ...

Artisan Partners Asset Management Inc. (APAM) Analysts See $0.67 EPS

Migdalia James

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.49, from 1.5 in 2017Q2. It worsened, as 19 investors ...

$1.67 EPS Expected for Andeavor (ANDV)

Stephen Andrade

Analysts expect Andeavor (NYSE:ANDV) to report $1.67 EPS on February, 5.They anticipate $1.69 EPS change or 8,450.00 % from last ...

American Superconductor Corporation (AMSC) Analysts See $-0.41 EPS

Vivian Park

Analysts expect American Superconductor Corporation (NASDAQ:AMSC) to report $-0.41 EPS on February, 5.They anticipate $0.17 EPS change or 70.83 % ...

Absolute Software Corporation (ALSWF) Analysts See $0.01 EPS

Marie Mckinney

Analysts expect Absolute Software Corporation (OTCMKTS:ALSWF) to report $0.01 EPS on February, 5.They anticipate $0.06 EPS change or 120.00 % ...

Akcea Therapeutics, Inc. (AKCA) Analysts See $-0.20 EPS

marketbeat

Analysts expect Akcea Therapeutics, Inc. (NASDAQ:AKCA) to report $-0.20 EPS on February, 5.After having $-0.18 EPS previously, Akcea Therapeutics, Inc.’s ...

« Previous PageNext Page »

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: